Townsend Letter The Examiner of Alternative Medicine
Alternative Medicine Conference Calendar
Check recent tables of contents


From the Townsend Letter
April 2008


Systemic Intracellular Bacterial Infections (Mycoplasma, Chlamydia, Borrelia species) in Neurodegenerative (Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's) and Behavioral (Autistic Spectrum Disorders) Diseases
by Prof. Garth L. Nicolson

Search this site

Page 1, Notes

1. Bertram L, Tanzi RE. The genetic epidemiology of neurodegenerative disease. J. Clin. Investig. 2005; 115:1449-1457.
2. Griffin WS. Inflammation and neurodegenerative diseases. Am. J. Clin. Nutr. 2006; 83:470S-474S.
3. Muravchick S, Levy RJ. Clinical implications of mitochondrial dysfunction. Anesthesiology. 2006; 105:819-837.
4. Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect or association? J. Clin. Invest. 2003; 111:163-169.
5. Bonuccelli U, Del Dotto P. New pharmacologic horizons in the treatment of Parkinson disease. Neurology. 2006; 67(Suppl 2):S30-S38.
6. Mattson MP. Infectious agents and age-related neurodegenerative disorders. Ageing Res. Rev. 2004; 3:105-120.
7. Bazala E, Renda J. Latent Chlamydial infections: the probably cause of a wide spectrum of human diseases. Med. Hypotheses. 2005; 65:578-584.
8. Koch AL. Cell wall-deficient (CWD) bacterial pathogens: could amyotrophic lateral sclerosis (ALS) be due to one? Crit. Rev. Microbiol. 2003; 29:215-221.
9. Nicolson GL, Nasralla M, Franco AR, et al. Mycoplasmal infections in fatigue illnesses: chronic fatigue and fibromyalgia syndromes, Gulf War illness and rheumatoid arthritis. J. Chronic Fatigue Syndr. 2000; 6(3/4):23-39.
10. Nasralla M, Haier J, Nicolson GL. Multiple mycoplasmal infections detected in blood of chronic fatigue and fibromyalgia syndrome patients. Eur. J. Clin. Microbiol. Infect. Dis. 1999; 18:859–65.
11. Nicolson GL, Nasralla M, Gan R, Haier J, De Meirleir K. Evidence for bacterial (mycoplasma, Chlamydia) and viral (HHV-6) co-infections in chronic fatigue syndrome patients. J. Chronic Fatigue Syndr. 2003; 11(2):7-20.
12. Evans R, Mavin S, Ho-Yen DQ. Audit of the laboratory diagnosis of Lyme disease in Scotland. J. Med. Microbiol. 2005; 54:1139-1141.
13. Mogilyansky E, Loa CC, Adelson ME, Mordechai E, Tilton RC. Comparison of Western immunoblotting and C6 Lye antibody test for laboratory detection of Lyme disease. Clin. Diagnost. Lab. Immunol. 2004; 11:924-929.
14. Williams DB, Windebank AJ. Motor neuron disease (amyotrophic lateral sclerosis). Mayo Clin. Proc. 1991; 66:54-82.
15. Swash M, Schwartz MS. What do we really know about amyotrophic lateral sclerosis? J. Neurol. Sci. 1992; 113:4-16.
16. Walling AD. Amyotrophic lateral sclerosis: Lou Gehrig's disease. Amer. Fam. Physician. 1999; 59:1489-1496.
17. Muir P, Nicholson F, Spencer GT, et al. Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease. J. Gen. Virol. 1996; 77:1469-1476.
18. Berger MM, Kopp N, Vital C, Redl B, Aymard M, Lina B. Detection and cellular localization of enterovirus RNA sequences in spial cord of patients with ALS. Neurology. 2000; 54:20-25.
19. Walker MP, Schlaberg R, Hays AP, Bowser R, Lipkin WI. Absence of echovirus sequences in brain and spinal cord of amyotrophic lateral sclerosis patients. Ann. Neurol. 2001; 49:249-253.
20. Nicolson GL, Berns P, Nasralla M, Haier J, Pomfret J. High frequency of systemic mycoplasmal infections in Gulf War veterans and civilians with amyotrophic lateral sclerosis (ALS). J. Clin. Neurosci. 2002; 9:525-529.
21. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362:59-62.
22. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N. Engl. J. Med. 1992; 326:1464-1468.
23. Hugan J. ALS therapy: targets for the future. Neurology. 1996; 47(Suppl 4):S251-S254.
24. Sobel RA. The pathology of multiple sclerosis. Neurol. Clin. 1995; 13:1-21.
25. Bruck W. Clinical implications of neuropathological findings in multiple sclerosis. J. Neurol. 2005; 252(Suppl 3):10-14.
26. Gilden DH. Infectious casues of multiple sclerosis. Lancet Neurol. 2005; 4:195-2002.
27. Sriram S, Stratton CW, Yao S, Tharp A, Ding L, Bannan JD, Mitchell WM. Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Ann. Neurol. 1999; 46:6-14.
28. Stratton CW, Sriram S. Association of Chlamydia pneumoniae with central nervous system disease. Microbes Infect. 2003; 5:1249-1253.
29. Stratton CW, Wheldon DB. Multiple sclerosis: an infectious syndrome involving Chlamydophia pneumoniae. Trends Microbiol. 2006; 14:474-479.
30. Layh-Schmitt G, Bendl C, Hildt U, Dong-Si T, Juttler E, Schnitzler P, Grond-Ginsbach C, Grau AJ. Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis. Ann. Neurol. 2000; 47:652-655.
31. Boman J, Roblin PM, Sundstrom P, Sandstrom M, Hammerschlag MR. Failure to detect Chlamydia pneumoniae in central nervous system of patients with MS. Neurology. 2000; 11:265.
32. Pucci E, Taus C, Cartechini E, Morelli M, Giuliani G, Clementi M, Menzo S. Lack of Chlamydia infection of the central nervous system in multiple sclerosis. Ann. Neurol. 2000; 48:399-400.
33. Swanborg RH, Whittum-Hudson JA, Hudson AP. Infectious agents and multiple sclerosis – Are Chlamydia pneumoniae and human herpes virus 6 involved? J. Neuroimmunol. 2003; 136:1-8.
34. Steiner I, Nisipianu P, Wirguin I. Infection and etiology and pathogenesis of multiple sclerosis. Curr. Neurol. Neurosic. Rep. 2001; 1:271-6276.
35. Lo SC, Buchholz CL, Wear DJ, et al. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systemically infected by Mycoplasma fermentans (incognitus strain). Mod. Pathol. 1991; 6:750-754.
36. Lo SC, Wear DJ, Shih WK, et al. Fatal systemic infections of non-human primates by Mycoplasma fermentans (incognitus strain). Clin. Infect. Dis. 1993; 17 (Suppl 1): S283-S288.
37. Keller JN. Age-related neuropathology, cognitive decline and Alzheimer's disease. Ageing Res. Rev. 2006; 5:1-13.
38. Masters CL, Beyreuther K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain. 2006; 129:2823-2839.
39. Drachman DA. Aging of the brain, entropy, and Alzheimer disease. Neurology. 2006; 67:1340-1352.
40. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch. Neurol. 2007; 64:954-956.
41. Daly MP. Diagnosis and management of Alzheimer disease. J. Am. Board Fam. Pract. 1999; 12:375-385.
42. Finch CE, Morgan TE. Systemic inflammation, infection, ApoE alleles and Alzheimer disease: a position paper. Curr. Alzheimer Res. 2007; 4:185-189.
43. Holmes C, El-Okl M, Williams AL, Cunningham C, Wilcockson D, Perry VH. Systemic infection, interleukin 1-beta and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry. 2003; 74:788-789.
44. Dobson CB, Wozniak MA, Itzhaki RF. Do infectious agents play a role in dementia? Trends Microbiol. 2003; 11:312-317.
45. Balin BJ, Appelt DM. Role of infection in Alzheimer's disease. J. Am. Osteopath. Assoc. 2001; 101(Suppl 12):S1-S6.
46. Yucesan C, Sriram S. Chlamydia pneumoniae infection of the central nervous system. Curr. Opin. Neurol. 2001: 14:355-359.
47. Balin BJ, Gerard HC, Arking EJ, Appelt DM, Branigan PJ, et al. Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain. Med. Microbiol. Immunol. 1998; 187:23-42.
48. Gerard HC, Dreses-Werringloer U, Wildt KS, Deka S, Oszust C, et al. Chlamydophila (Chlamydia) penumoniae in the Alzheimer's brain. FEMS Immunol. Med. Microbiol. 2006; 48:355-366.
49. MacIntyre A, Abramov R, Hammond CJ, Hudson AP, et al. Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells. J. Neurosci. Res. 2003; 71:740-750.
50. Little CS, Hammond CJ, MacIntyre A, Balin BJ, Appelt DM. Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice. Neurobiol. Aging. 2004; 25:419-429.
51. Ring RH, Lyons JM. Failure to detect Chlaymdia pneumoniae in the late-onset Alzheimer's brain. J. Clin. Microbiol. 2000; 38:2591-2594.
52. Gieffers J, Reusche E, Solbach W, Maass M. Failure to detect Chlamydia pneumoniae in brain sections of alzheimer's disease patients. J. Clin. Microbiol. 2000; 38:881-882.
53. Meer-Scheerer L, Chang Loa C, Adelson ME, Mordechai E, Lobrinus JA, Fallon BA, Tilton RC. Lyme disease associated with Alzheimer's disease. Curr. Microbiol. 2006; 52:330-332.
54. Pappolla MA, Omar R, Saran B, Andorn A, Suarez M, et al. Concurent neuroborreliosis and Alzheimer's disease: analysis of the evidence. Hum. Pathol. 1989; 20:753-757.
55. MacDonald AB. Alzheimer's disease Braak Stage progressions: reexamined and redefined as Borrelia infection transmission through neural circuits. Med. Hypotheses. 2007; 68:1059-1064.
56. Miklossy J, Khalili K, Gern L, Ericson RL, Darekar P, Bolle L, Hurlimann J, Paster BJ. Borrelia burgdorferi persists in the brain in chronic Lyme neuroborreliosis and may be associated with Alzheimer's disease. J. Alzheimer's Dis. 2004; 6:639-649.
57. MacDonald AB. Plaques of Alzheimer's disease orginate from cysts of Borrelia Burgdorferi, the Lyme disease spirochete. Med. Hypotheses. 2006; 67:592-600.
58. Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J. Mol. Neurosci. 2001; 17:137-135.
59. Marques AR, Weir SC, Fahle GA, Fischer SH. Lack of evidence of Borrelia involvement in Alzheimer's disease. J. Infect. Dis. 2000; 182:1006-1007.
60. Denaro FJ, Staub P, Colmer J, Freed DM. Coexistance of Alzheimer's disease neuropathology with Herpes Simplex encephalitis. Cell Mol. Biol. 2003; 49:1233-1240.
61. Lin WR, Shang D, Itzhaki RF. Neurotrophic viruses and Alzheimer's disease. Interaction of Herpes Simplex type-1 virus and apolipoprotein E in the etiology of the disease. Mol. Chem. Neuropathol. 1996; 28:135-141.
62. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes Simplex Virus type 1 in brain and risk of Alzheimer's disease. Lancet. 1997; 349:241-244.
63. Shipley SJ, Parkin ET, Itzhaki RF, Dobson CB. Herpes Simplex virus interferes with amyloid precursor protein processing. BMC Microbiol. 2005; 5:48.
64. Rimland B. The Autism epidemic, vaccinations and mercury. J. Nut. Environ. Med. 2000; 10:261–266.
65. Downing D. Mercury again. J. Nut. Environ. Med, 2000; 10:267–269.
66. Nicolson GL. Chronic infections as a common etiology for many patients with chronic fatigue syndrome, fibromyalgia syndrome and Gulf War Illnesses. Intern. J. Med. 1998; 1:42–46.
67. Nicolson GL, Nasralla M, Hier J, Erwin R, Nicolson NL. Mycoplasmal infections in chronic illnesses: fibromyalgia and chronic fatigue syndromes, Gulf War illness, HIV-AIDS and rheumatoid arthritis. Med. Sentinel, 1999; 4:172–176.
68. Nicolson GL, Nasralla M, Franco AR, De Meirlier K, Nicolson NL, Ngwenya R, Haier J. Mycoplasmal infections in fatigue illnesses: chronic fatigue and fibromyalgia syndromes, Gulf War illness and rheumatoid arthritis. J. Chronic Fatigue Syndr. 2000; 6(3):23–39.
69. Thornton D. A survey of Mycoplasma detection in vaccines. Vaccine. 1986; 4:237–240.
70. Nicolson, GL, Nasralla MY, Nicolson NL, Haier J. High prevalence of mycoplasmal infections in symptomatic (chronic fatigue syndrome) family members of mycoplasma-positive Gulf War Illness patients. J. Chronic Fatigue Syndr, 2003; 11(2):21-36.
71. Nicolson GL, Nicolson NL. Chronic fatigue illness and Operation Desert Storm. J. Occup. Environ. Med. 1996; 38:14-16.
72. Nicolson GL, Nicolson NL. Diagnosis and treatment of mycoplasmal infections in Persian Gulf War Illness-CFIDS patients. Intern. J. Occup. Med. Immunol. Tox. 1996; 5:69–78.
73. Nicolson GL, Berns P, Gan R, Haier J. Chronic mycoplasmal infections in Gulf War veterans' children and autism patients. Med. Veritas. 2005; 2:383-387.
74. Nicolson GL, Nicolson NL, Nasralla M. Mycoplasmal infections and Chronic Fatigue Illness (Gulf War Illness) associated with deployment to Operation Desert Storm. Intern. J. Med, 1998; 1:80–92.
75. Nicolson GL, Gan R, Nicolson NL, Haier J. Evidence for Mycoplasma, Chlamydia pneunomiae and HHV-6 Co-infections in the blood of patients with autism spectrum disorders. J. Neuroscience Res. 2007; 85:1143-1148.
76. Morrison JD. Fatigue as a presenting complaint in family practice. J. Fam. Pract. 1980; 10:795-801.
77. Fukuda K, Strauss SE et al. The chronic fatigue syndrome, a comprehensive approach to its definition and study. Ann. Intern. Med. 1994; 121:953-959.
78. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990: 33:160-172.
79. Nicolson GL, Gan R, Haier J. Multiple co-infections (Mycoplasma, Chlamydia, human herpesvirus-6) in blood of chronic fatigue syndrome patients: association with signs and symptoms. Acta Pathol. Microbiol. Immunol. Scand. 2003; 111:557-566.
80. Nicolson, G.L., Nicolson, N.L, Haier, J. Chronic fatigue syndrome patients subsequently diagnosed with Lyme disease Borrelia burgdorferi: evidence for Mycoplasma species co-infections. J. Chronic Fatigue Syndr. 2008; in press.
81. Nicolson GL, Gan R, Haier J. Evidence for Brucella spp. and Mycoplasma spp. co-Infections in blood of Chronic Fatigue Syndrome patients. J. Chronic Fatigue Syndr. 2005; 12(2):5-17.
82. Burgdorfer WA, Barbour AG, Hayes SF, et al. Lyme disease – a tick-borne spirochetosis? Science 1982; 216:1317-1319.
83. Kind A, Schned E, Anderson F, et al. Lyme disease guidelines for Minnesota clinicians: epidemiology, microbiology, diagnosis, treatment and prevention. Minnesota Department of Public Health, 1999.
84. Gale A, Ringdahl E. Tick-borne diseases. Amer. Fam. Physician. 2001; 64:461-466.
85. Nicolson, G.L. Diagnosis and therapy of chronic systemic co-infections in Lyme disease and other tick-borne infectious diseases. Townsend Lett. 2007; 285:93-98.
86. Verdon ME, Sigal LH. Recognition and management of Lyme disease. Amer. Fam. Physician. 1997; 56:427-436.
87. Klempner MS, et al. Intralaboratory reliability of serologic and urine testing for Lyme disease. Amer. J. Med. 2001: 110:217-219.
88. Eskow E, Adelson ME, Rao RV, Mordechai E. Evidence for disseminated Mycoplasma fermentans in New Jersey residents with antecedent tick attachment and subsequent musculoskeletal symptoms. J. Clin. Rheumatol. 2003; 9:77-87.
89. Mitchell PD, Reed KD, Hofkes JM. Immunoserologic evidence of coinfection to tick-borne pathogens of babesiosis, ehrlichiosis and Lyme borrelosis in human sera. J. Clin. Microbiol. 1996; 34:724-727.
90. Belongia EA, Reed KD, Mitchell PD, et al. Clinical and epidemiological features of early Lyme disease and human granulocytic ehrlichiosis in Wisconsin. Clin. Infect. Dis. 1999; 29:1472-1477.
91. Eskow E, Rao R-V, Mordechai E. concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae. Arch. Neurol. 2001; 58:1357-1363.
92. Armengol CE, Hendley JD. Cat-scratch disease encepthalopathy: a cause of status epilepticus in school-aged children. J. Pediatr. 1999; 134:635-638.
93. Mylonakis E. When to suspect and how to monitor Babesiosis. Amer. Family Physican. 2001; 63:1969-1974.
94. Nicolson GL, Nasralla M, Franco AR, Nicolson NL, Erwin R, Ngwenya R, Berns PA. Diagnosis and integrative treatment of intracellular bacterial infections in Chronic Fatigue and Fibromyalgia Syndromes, Gulf War Illness, Rheumatoid Arthritis and other chronic illnesses. Clin. Pract. Alt. Med. 2000; 1(2): 92-102.
95. Nicolson GL, Ngwenya R. Dietary considerations for patients with chronic illnesses and multiple chronic infections. A brief outline of eighteen dietary steps to better health. Townsend Lett. 2001; 219:62-65
96. Nicolson, G.L. Lipid replacement as an adjunct therapy in chronic fatigue, anti-aging and restoration of mitochondrial function. J. Am. Nutraceut. Assoc. 2003; 6(3): 22-28.
97. Nicolson, G.L. Lipid replacement and antioxidant supplements to prevent membrane oxidation and restore mitochondrial function in metabolic syndrome and fatiguing illnesses. Townsend Lett. 2007; 286: 112-120


Consult your doctor before using any of the treatments found within this site.

Subscriptions are available for Townsend Letter, the Examiner of Alternative Medicine magazine, which is published 10 times each year.

Search our pre-2001 archives for further information. Older issues of the printed magazine are also indexed for your convenience.
1983-2001 indices ; recent indices

Once you find the magazines you'd like to order, please use our convenient form, e-mail, or call 360.385.6021 (PST).


Who are we? | New articles | Featured topics |
Tables of contents
| Subscriptions | Contact us | Links | Classifieds | Advertise | Alternative Medicine Conference Calendar | Search site | Archives |
EDTA Chelation Therapy | Home


© 1983-2008 Townsend Letter for Doctors & Patients
All rights reserved.
Website by Sandy Hershelman Designs
April 27, 2008

Order back issues
Advertise with TLDP!

Visit our pre-2001 archives